TCL Archive Contract Proposal Would Assess Outcomes Other Than Incidence, Response, Mortality September 18, 1987
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations February 3, 1984